Return-path: <bounce-18416124_HTML-982008319-35789156-10831462-395@bounce.broadcastemail.asco.org>
Envelope-to: info@seeinindia.com
Delivery-date: Tue, 31 Mar 2015 22:10:47 +0000
Received: from mta.broadcastemail.asco.org ([64.132.92.206]:40736)
	by bh-in-11.webhostbox.net with esmtp (Exim 4.82)
	(envelope-from <bounce-18416124_HTML-982008319-35789156-10831462-395@bounce.broadcastemail.asco.org>)
	id 1Yd4Mv-000Ijj-ED
	for info@seeinindia.com; Tue, 31 Mar 2015 22:10:46 +0000
Received: by mta.broadcastemail.asco.org id h3cdma163hs6 for <info@seeinindia.com>; Tue, 31 Mar 2015 16:10:43 -0600 (envelope-from <bounce-18416124_HTML-982008319-35789156-10831462-395@bounce.broadcastemail.asco.org>)
From: "ASCO Express" <express@asco.org>
To: <info@seeinindia.com>
Subject: =?UTF-8?B?QVNDTyBQcmVzaWRlbnQgRHIuIFBldGVyIFBhdWwgWXUgSW52aXRl?=
 =?UTF-8?B?cyBZb3UgdG8gdGhlIDIwMTUgQW5udWFsIE1lZXRpbmc7IENhbmNlcjogVGhl?=
 =?UTF-8?B?IEVtcGVyb3Igb2YgQWxsIE1hbGFkaWVzIOKAkyBUaGUgU3Rvcnkgb2YgT3Vy?=
 =?UTF-8?B?IFByb2Zlc3Npb24=?=
Date: Tue, 31 Mar 2015 16:10:42 -0600
List-Unsubscribe: <mailto:leave-fc5015787165027c77101f2d205921-fe271d7877640475761579-fe531775726c0d7c7012-fe6615707d6705797316-ff5e177970@leave.broadcastemail.asco.org>
MIME-Version: 1.0
x-job: 10831462_35789156
Message-ID: <8d9ff2e5-66f3-42c1-b1e1-852682a8d3ab@xtinmta1213.xt.local>
Content-Type: multipart/alternative;
	boundary="8T1XV8FMHUz6=_?:"
X-Authenticated_sender: 

This is a multi-part message in MIME format.

--8T1XV8FMHUz6=_?:
Content-Type: text/plain;
	charset="us-ascii"
Content-Transfer-Encoding: 7bit

To view this email as a web page, go to the link below, or copy and paste it into your browser's address window.
http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd661d3a52922ca83027993f5698ab0deb2d1b28b58c62c6a435167adecdbdeacb

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd21da6a82401d681b382f057c9fe4fa180540f5c208646d9467bf61060839da90 
Sign in to MyASCO 

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd21da6a82401d681b382f057c9fe4fa180540f5c208646d9467bf61060839da90 

Briefing for Alicia Alicia
March 31, 2015 

Browse by Category
ASCO in Action  |  Meetings  | Grants & Awards | Journals |  ASCO Connection  |  Education & Training |  For Your Patients 

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd05fe32a5bff95c8f58acc8e0477231236fe168eff11b4d00fa48b5189d7d5380 
Open Comment Period for Draft Colorectal Cancer Molecular Marker Testing Guideline

ASCO, in partnership with three other medical societies, has announced the start of the public open comment period for a new clinical practice guideline being developed for patients with advanced colorectal cancer.  Please visit 
http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd05fe32a5bff95c8f58acc8e0477231236fe168eff11b4d00fa48b5189d7d5380 
www.amp.org/CRC to provide feedback by April 22.

  

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd05fe32a5bff95c8f58acc8e0477231236fe168eff11b4d00fa48b5189d7d5380 

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdbd0054c04e2a8323ee1a6922aafc94ce7818f69ff6f5ee9eeb684e5b2901c95e 

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdbd0054c04e2a8323ee1a6922aafc94ce7818f69ff6f5ee9eeb684e5b2901c95e 
2014 ASCO Annual Report: A Year of Exciting Accomplishments »

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bde382c99c149b2a5fa43de48c1ba09846215cac923884c3321153a9ed26e7eeb7 

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bde382c99c149b2a5fa43de48c1ba09846215cac923884c3321153a9ed26e7eeb7 
Cancer: The Emperor of All Maladies &ndash; The Story of Our Profession >>

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd1ad6c8c2df397ae59a2adbe99c791690d2588e2d989400db18b0e296a8962f5e 

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd1ad6c8c2df397ae59a2adbe99c791690d2588e2d989400db18b0e296a8962f5e 
ASCO President Peter Paul Yu, MD, FACP, FASCO, Invites You to the 2015 Annual Meeting »

ASCO in Action

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd867c992fc3356549672aacfe4caaed9c0c0faa0e4984d008d8d88d718191abfd 
Senate Delays Vote on SGR Repeal; Ongoing Action Needed »


http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd3132f691aefff5a6c61dd3cfdc28e563526cd6882700a45e9becf9941dea47e3 

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd1ad8d9aefea7fef3e3ea8b220177b7fb88091df54f2871d2a5782bbe67398925 
Congress Takes Closer Look at 340B Program »

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bddcac3fef7d90b16f32b6aaa92af80f7e7e781101081ce8cb974e9dd882c4a68f 
FDA's Biosimilar Product Approval Process: A Closer Look »

Journals

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdca08709a1010c5433aeb27de38d01cc24b479f8ca3cfe2b63b8bedfcd65586d9 
JOP Publishes The State of Cancer Care in America: 2015 »

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bda92f2a41f9c8ebe414fd28321aad574a27569a59f34d21a5c67244a67871a1bc 
JCO's Understanding the Pathway: Should the adjuvant trial results lead us away from testing PI3K inhibitors in HER2-positive breast cancer? »

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd7351aa32cad04387501f17bad144f7d96914176ce17e0d64652b64c99b060ac4 
Guidance on Lapatinib Versus Trastuzumab in Metastatic Breast Cancer »

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdd655c00fca30857eaafbb083dd244f27d75279a90acd4ec1c488fd6555e8fffb 
JOP Exclusive Coverage: Drug Shortages Disproportionately Affect Smaller Practices »
Full Journals

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdda666f90b30e05737cedab4ebef5a18eb12442f78a5bc5774913ed9ee6179701 
Journal of Clinical Oncology 

Original Reports » 

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdd9ba5cdf9ae142eb4405c3fb46e826dd7adae02a0b9f73cf8c3f16763af429e5 
Journal of Oncology Practice » 

  

ASCO Connection

ASCO's professional networking site for the worldwide oncology community

New Commentary
http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd7de35d8f471e1fe292720af713878428587c842238bca871ce3488678aebeca8 


How to Assure Patients in the Face of ASSURE by Sumanta K. Pal, MD, and Nicholas Vogelzang, MD, FASCO

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd3e4f41a2ab94121df0840e92e203083646539367296cd18f4916eeba37e8a5d7 
Through the Eyes of a Child by Don S. Dizon, MD, FACP 
http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd2dfed76e666504897474f1b8c6af80b1767f692ebcf614d25c4fe1554c2c86ab 
@drdonsdizon

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd67d7c33bde54a1ef93ae6f26dfc57798e34a81860e6c3a9da0280ba0e8b81224 
Unintended Consequences by Nathan A. Pennell, MD, PhD 
http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdb3b1c4f0e197a331a505880dd5dd4524e7f40c968fbdaa9205411db24a83d2e3 
@n8pennell


Log in to 
http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd6c2e7e82c99e7494ad6a1726aec138acccf5d3f29a2f69392808f83555edac5d 
ASCOconnection.orgto respond.

Meetings

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd72e293e1d929d80c1d754de80a510aef9184b3862336674455eeafa4c91cd176 
2015 ASCO Annual Meeting »
May 29-June 2 in Chicago, Illinois
Register and Reserve Your Hotel by April 22, 2015, at 11:59 PM (EDT)

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd421ebe97bcda5c6546d3c3bd8f6327516574a6ceb6e8756d41299a220f6d751e 
Save the Date: Best of ASCO(r) 2015 »
July 31-August 1 in Boston, Massachusetts

August 7-8 in San Francisco, California

August 28-29 in Chicago, Illinois


http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdbd620ccd44eea3be7826bcd259e2d268d58184c260e997986c869c009a245d8e 
Save the Date: Community Research Forum 2015 Annual Meeting »
September 20-21 in Alexandria, Virginia

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdb46d1b3e04f3366f6a34eb7694a0ccd81f3e67b870cb428c18f9288e91c0632b 
Save the Date: 2015 Breast Cancer Symposium »
September 25-27 in San Francisco, California

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd4caf51c3df62ade401009f2d287409a0a51b0604142b33f8f7e92fa1244ccd33 
Save the Date: 2015 Palliative Care in Oncology Symposium »
October 9-10 in Boston, Massachusetts


http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd89e9551d711f9f56f79dc66302a46a8203a76fac4bcd8700db976cc7a2e7c97a 
Announcing the Inaugural 2016 Cancer Survivorship Symposium: Advancing Care and Research »
January 15-16, 2016 in San Francisco, California

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd322e831cd592ca6b69a228f0adb73ea25d4f116e0243b4891ba049db4ea871b2 
See All Upcoming Meetings »

Education & Training

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd1e34460aa56b1ea71271ebb4b7494d49096a7e51982e0dcd2c349b6964f9d4a0 

New CME-Accredited Tumor Board on ASCO University: BRCA-Associated Breast Cancer »

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdffa3e4f1d3e8ee194423bac8e7c89184d6aa71011675336f579388256f1bf1d7 
Fulfill ABIM Requirements with New Lung Cancer MOC Course »

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd219d73347e113eeef15bec92011ab8807a89f220b349e3a84859c976e8cb0e53 
Missed the Genitourinary Cancers Symposium? Get Access to the Science Presented with Virtual Meeting »

For Your Patients

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd363a514534055d406788814801d863477abcc58937cb5df2dfb3a0f2bc886009 


Dr. Brian Rini Provides an Overview of Kidney Cancer in New Cancer.Net Video »

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd8231fe70ce882b8f0579075c2c4b96494940e6a403c220b4884a7cffe2d65aca 
Now on the Cancer.Net Blog: A Behind-the-Scenes Q&A with Pathologists »

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdd56229a8e864a69e83bcfe98656e5817b0ffdc9d172b42a3b64e73613962912e 
Follow us on 
http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdd56229a8e864a69e83bcfe98656e5817b0ffdc9d172b42a3b64e73613962912e 
Twitter

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd3f38a702ad989f1f8c90bbae08493e53dd734ed67400edd894f07b8cbfe324fd 
Like us on 
http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd3f38a702ad989f1f8c90bbae08493e53dd734ed67400edd894f07b8cbfe324fd 
Facebook

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd2e4f2e23faede4a14cc428b7f22ac4cd2abacab8a02ca46c533218c65c94e1a8 
Follow us on 
http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd2e4f2e23faede4a14cc428b7f22ac4cd2abacab8a02ca46c533218c65c94e1a8 
LinkedIn

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdeb1c3331815fb9ed2c5fe37e42795a9a23b0240f7d0bd0776f5497c9ad6a0312 
 Watch us on 
http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdeb1c3331815fb9ed2c5fe37e42795a9a23b0240f7d0bd0776f5497c9ad6a0312 
YouTube

http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdfca59924ec46b242e6f2f8a0755f63eeb41dc30dd405141f012d433dba6a3944 
Network on 
http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdfca59924ec46b242e6f2f8a0755f63eeb41dc30dd405141f012d433dba6a3944 
ASCO Connection

The Conquer Cancer Foundation supports many of ASCO's programs. 
http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd6e1bf415f7d2756ee92af6e3bb532ec09cbfffea9f821a113bc4a42a72e92f49 
Click here  to join us in building a world free from the fear of cancer.








You are receiving this email because you have an existing relationship
with ASCO.  Visit your personalized 
http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd54f45d2ece660151393ffccde3ec2a500fadee46ef6ea88f4b7a7d68ca5d4447aa17cdd1b68e8318 
Preference Center  to unsubscribe or to select
your preferences for receiving ASCO promotional email.  Please do
not reply to this email.  

This email was sent by: American Society of Clinical Oncology

2318 Mill Road, Suite 800 Alexandria, VA,
22314, USA



--8T1XV8FMHUz6=_?:
Content-Type: text/html;
	charset="us-ascii"
Content-Transfer-Encoding: 7bit

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<div style="display:block;width:100%;text-align:center;font-family: Verdana, sans-serif;font-size:10px;color:#444444;padding:8px 0;margin:auto;">
	To view this email as a web page, go   <a href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdc50cc10bde362e2293e940b3bd32e1173336e811a99997ddd60ea8c430f243b3" > here</a>.
</div><!-- ET01.12 -->

	<!-- Table used to center email -->
	<table border="0" cellpadding="0" cellspacing="0" width="100%">
		<tr>
			<td align="left" width="100%" bgcolor="#00447b">
				<div align="center">
					<!-- Table used to set width of email margin -->
					<table border="0" cellpadding="0" cellspacing="0" width="640">
						<tr>
							<td align="left" width="600">
								<div align="center">
									<!-- Table used to set width of email content -->
									<table border="0" cellpadding="0" cellspacing="0" width="600">
										<tr>
											<td align="left" width="600">
												<!-- Begin Content -->
												<table border="0" cellpadding="0" cellspacing="0" width="600">
													<!-- Preheader -->
													<tr>
														<td align="left" width="600" style="padding: 5px 0px 5px 0px;"></td>
													</tr>
													<!-- Header -->
													<tr>
														<td align="left" width="600" bgcolor="#ffffff">
															<table cellpadding="0" cellspacing="0" border="0" width="600">
																<tr>
																	<td align="left" width="410" height="10"><img alt="" src="http://image.broadcastemail.asco.org/lib/fe66157077670d7f7712/m/1/ASCO_Header_LeftCorner.gif" width="410" height="10" border="0" style="display: block;"></td>
																	<td align="left" width="190" height="10" bgcolor="#81a1b6"><img alt="" src="http://image.broadcastemail.asco.org/lib/fe66157077670d7f7712/m/1/ASCO_Header_RightCorner.gif" width="190" height="10" border="0" style="display: block;"></td>
																</tr>
																<tr>
																	<td align="left" width="410" height=""></td>
																	<td align="left" width="137" height="" bgcolor="#81a1b6" style="padding: 0px 30px 10px 10px;">
																		<table cellpadding="0" cellspacing="0" border="0" width="100%">
																			<tr>
																				<td align="left" width="" height="" style="font-family: Helvetica, Arial, sans-serif; font-size: 13px; font-weight: bold; color: #ffffff; text-align: right; -webkit-text-size-adjust: none; margin: 0px;"><a href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd3b21f93cdb41185113ec7e60665bf331733a9d9edec7ca02309c8513f50a521c"  target="_blank" style="color: #ffffff; text-decoration: none;">Sign in to MyASCO</a></td>
																				<td align="left" valign="middle" width="13" height="13"><img alt="" src="http://image.broadcastemail.asco.org/lib/fe66157077670d7f7712/m/1/ASCO_Header_Arrow.gif" width="13" height="13" border="0" style="display: block;"></td>
																			</tr>
																		</table>
																	</td>
																</tr>
															</table>
														</td>
													</tr>
													<tr>
														<td align="left" width="600" bgcolor="#ffffff">
															<table cellpadding="0" cellspacing="0" border="0" width="600">
																<tr>
																	<td align="left" width="305" height="" style="padding: 0px 0px 0px 30px;"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><a title="ASCO Express" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd83ded6dce39154adcb457165d1765ad75bf3348786100568d69f82202a0e5ce6"  >
<img style="border-color: #000000; margin: 0px; width: 275px; height: 34px;" title="ASCO_ExpressLogo" alt="ASCO_ExpressLogo" src="http://image.broadcastemail.asco.org/lib/fe66157077670d7f7712/m/1/ASCO_ExpressLogo.jpg" mdid="6f54f3e7-3542-472b-bcd6-8b4c484d8812" border="0" height="34" width="275" /></a></td></tr></table></td></tr></table></td>
																	<td align="left" width="105" style="padding: 0px;"></td>
																	<td align="left" valign="middle" width="190" height="" style="font-family: Helvetica, Arial, sans-serif; font-size: 13px; font-weight: bold; color: #7d7d7d; text-align: right; padding: 0px 30px 0px 10px;">Briefing for Alicia Alicia</td>
																</tr>
																<tr>
																	<td width="285" height="" align="left" style="font-family: Helvetica, Arial, sans-serif; font-size: 13px; font-weight: normal; color: #7d7d7d; padding: 3px 0px 10px 30px;">March 31, 2015</td>
																	<td width="125" height="" align="left" style="font-family: Helvetica, Arial, sans-serif; font-size: 13px; font-weight: normal; color: #7d7d7d; padding: 3px 0px 10px 30px;">&nbsp;</td>
																	<td align="left" width="190" height="" style="padding: 0px 30px 0px 10px;"></td>
																</tr>
															</table>
														</td>
													</tr>
													<tr>
														<td align="left" width="600" style="padding: 5px 0px 5px 0px;"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><font color="#db681f"><strong>Browse by Category</strong> <br />
</font><font size="1" color="#ffffff"><a conversion="undefined" alias="ASCO in Action" href="#ASCO%20in%20Action" title="ASCO in Action"><font color="#ffffff">ASCO in Action</font></a>&nbsp; |&nbsp; <a conversion="undefined" alias="Meetings" href="#Meetings" title="Meetings"><font color="#ffffff">Meetings</font></a>&nbsp; | <a conversion="undefined" alias="Grants & Awards" href="#Grants%20and%20Awards" title="Grants & Awards"><font size="1" color="#ffffff">Grants & Awards</font></a><font size="1" color="#ffffff"> | </font><a conversion="undefined" alias="Journals " href="#Journals" title="Journals "><font size="1" color="#ffffff">Journals</font></a>
<font size="1" color="#ffffff">&nbsp;|&nbsp; <a conversion="undefined" alias="ASCO Connection" href="#ASCO%20Connection" title="ASCO Connection"><font color="#ffffff">ASCO Connection</a></font>&nbsp; |&nbsp;&nbsp;<a conversion="undefined" alias="ASCO Connection" href="#ASCO%20Connection" title="ASCO Connection"><font color="#ffffff">Education & Training</a> | </font>&nbsp;<a conversion="undefined" alias="For Your Patients" href="#For%20Your%20Patients" title="For Your Patients"><font color="#ffffff">For Your Patients</font></a>&nbsp;<br />
</font></td></tr></table></td></tr></table></td>
													</tr>
													<!-- Email Body -->
													<tr>
														<td align="left" width="600" bgcolor="#ffffff">
															<table border="0" cellpadding="0" cellspacing="0" width="600">
																<tr>                                             
																	<td align="left" width="600"></td>
																</tr>
																<tr>                                             
																	<td align="left" width="600" style="padding: 20px 30px 30px 30px;">
																		<table cellpadding="0" cellspacing="0" border="0" width="100%">
																			<tr>
																				<td align="left" width="540" height="">
																					<table cellpadding="0" cellspacing="0" border="0" width="540">
																						<tr>
																							<td align="left" valign="top" width="350" height="" style="padding: 0px 30px 0px 0px;"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><strong><span style="font-size: 18px;"><a   title="Open Comment Period for Draft Colorectal Cancer Molecular Marker Testing Guideline" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdd55b1725e9e330f413cbccfa1865684a19ef2c68673c6640d35cae15c09ffb6f" style="text-decoration: none;"><font color="#00447d">Open Comment Period for Draft Colorectal Cancer Molecular Marker Testing Guideline</font></a></span></strong>
<font color="#00447d"><br />
<br />
<font color="#959595">ASCO, in partnership with three other medical societies, has announced the start of the public open comment period for a new clinical practice guideline being developed for patients with advanced colorectal cancer.&nbsp; Please visit </font><font color="#959595"><a   title="Open Comment Period for Draft Colorectal Cancer Molecular Marker Testing Guideline" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdd55b1725e9e330f413cbccfa1865684a19ef2c68673c6640d35cae15c09ffb6f" style="text-decoration: none;"><font color="#00447d">www.amp.org/CRC</font></a><font color="#959595"><font color="#959595"> to provide feedback by April 22.</font><font color="#959595"><font color="#959595"><font color="#959595"><br />
&nbsp;&nbsp;<br />
</font></font></font></font></font></font></td></tr></table></td></tr></table></td>
																							<td align="left" valign="top" width="160" height=""><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><div align="center">
<a title="Open Comment Period for Draft Colorectal Cancer Molecular Marker Testing Guideline" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdd55b1725e9e330f413cbccfa1865684a19ef2c68673c6640d35cae15c09ffb6f"  ><img vspace="0" hspace="0" border="0" src="http://image.broadcastemail.asco.org/lib/fe6615707d6705797316/m/1/Guidelines+lead.jpg" title="ASCO Guidelines" alt="ASCO Guidelines" /></a>
</div></td></tr></table></td></tr></table></td>
																						</tr>
																					</table>
																				</td>
																			</tr>
																			<tr>
																				<td align="left" width="540" height="">
																					<table cellpadding="0" cellspacing="0" border="0" width="540">
																						<tr>
																							<td align="left" valign="top" width="540" height=""><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><table width="100%" cellspacing="0" cellpadding="0" bgcolor="#ffffff" class="dashedBorder">
	<tbody>
		<tr>
			<td valign="middle" height="4" bgcolor="#dbdfea" align="left" style="font-family: Arial; height: 4px; font-size: 13px;"></td>
		</tr>
		<tr>
			<td valign="middle" height="2" bgcolor="#ffffff" align="left" style="font-family: Arial; height: 2px; font-size: 13px;"></td>
		</tr>
		<tr>
			<td valign="middle" height="2" bgcolor="#dbdfea" align="left" style="font-family: Arial; height: 2px; font-size: 13px;"></td>
		</tr>
	</tbody>
</table>
<br /></td></tr></table></td></tr></table></td>
																						</tr>
																					</table>
																				</td>
																			</tr>
																			<tr>
																				<td align="left" width="540" height="">
																					<table cellpadding="0" cellspacing="0" border="0" width="540">
																						<tr>
																							<td align="left" valign="top" width="255" height="" style="padding: 0px 30px 0px 0px;"></td>
																							<td align="left" valign="top" width="255" height=""></td>
																						</tr>
																					</table>
																				</td>
																			</tr>
																			<tr>
																				<td align="left" width="540" height="">
																					<table cellpadding="0" cellspacing="0" border="0" width="540">
																						<tr>
																							<td align="left" valign="top" width="160" height="" style="padding: 0px 30px 0px 0px;"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><br />
<table width="100%" cellspacing="0" cellpadding="0" bgcolor="#ffffff" class="dashedBorder">
	<tbody>
		<tr>
			<td style="font-family: Arial; font-size: 13px;"></td>
		</tr>
		<tr>
			<td valign="middle" bgcolor="#ffffff" align="center" style="font-family: Arial; font-size: 13px;"><a title="2014 ASCO Annual Report" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdc2b449984c4e1b34fad5af09d569b5eea91d8bc0eb134705c745e67124f215cd"  ><img width="160" height="70" border="0" style="width: 160px; height: 70px; border-color: #000000; margin: 0px;" alt="2014 Annual Report pod" title="2014 Annual Report pod" src="http://image.broadcastemail.asco.org/lib/fe6615707d6705797316/m/1/2014+Annual+Report+pod.jpg" /></a></td>
		</tr>
		<tr>
			<td style="font-family: Arial; font-size: 13px;">
			<p>
			<font color="#959595"><font size="2" face="Arial"><a style="text-decoration: none;" title="2014 ASCO Annual Report" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdc2b449984c4e1b34fad5af09d569b5eea91d8bc0eb134705c745e67124f215cd"  ><font color="#00447d">2014 ASCO Annual Report: A Year of Exciting Accomplishments &#187;</font></a></font> </font>
			</p>
			</td>
		</tr>
	</tbody>
</table></td></tr></table></td></tr></table></td>
																							<td align="left" valign="top" width="160" height="" style="padding: 0px 30px 0px 0px;"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><table width="100%" cellspacing="0" cellpadding="0" bgcolor="#ffffff" class="dashedBorder">
	<tbody>
		<tr>
			<td style="font-family: Arial; font-size: 13px;"></td>
		</tr>
		<tr>
			<td valign="middle" bgcolor="#ffffff" align="left" style="font-family: Arial; font-size: 13px;"><a title="Cancer: The Emperor of All Maladies &ndash; The Story of Our Profession" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd9e00401297ca4128464bd575372af08710b6ac910a6ea5ff993300e16abbfce4"  ><img width="160" height="90" border="0" style="width: 160px; height: 90px; border-color: #000000; margin: 0px;" alt="Emperor of All Maladies pod" title="Emperor of All Maladies pod" src="http://image.broadcastemail.asco.org/lib/fe6615707d6705797316/m/1/Emperor+of+All+Maladies+pod.jpg" /><br />
			</a>
			<font size="2" face="Arial"><font color="#959595"><a style="text-decoration: none;" title="Cancer: The Emperor of All Maladies &ndash; The Story of our Profession" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdb1cf60d03de6f198042f39a2aba3f5bbfd30c2482a66b0301750955a91a07116"  ><font color="#00447d"><i>Cancer: The Emperor of All Maladies</i> &ndash; The Story of Our Profession &raquo;</font></a><br />
			</font>
			</font>
			</td>
		</tr>
	</tbody>
</table></td></tr></table></td></tr></table></td>
																							<td align="left" valign="top" width="160" height=""><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><table width="100%" cellspacing="0" cellpadding="0" bgcolor="#ffffff" class="dashedBorder">
	<tbody>
		<tr>
			<td style="font-family: Arial; font-size: 13px;"></td>
		</tr>
		<tr>
			<td valign="middle" bgcolor="#ffffff" align="center" style="font-family: Arial; font-size: 13px;"><a   href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd6868eabcc9ee62ec54180cf04f84b5452c70484e43a7fd4a32d61797fec9c8a1" title="ASCO President Peter Paul Yu, MD, FACP, FASCO, Invites You to the 2015 ASCO Annual Meeting"><img vspace="0" hspace="0" border="0" alt="YT pod" title="YT pod" src="http://image.broadcastemail.asco.org/lib/fe6615707d6705797316/m/1/YT+pod.jpg" /></a></td>
		</tr>
		<tr>
			<td style="font-family: Arial; font-size: 13px;">
			<p>
			<font color="#959595"><font size="2" face="Arial"><a style="text-decoration: none;"   href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd6868eabcc9ee62ec54180cf04f84b5452c70484e43a7fd4a32d61797fec9c8a1" title="ASCO President Peter Paul Yu, MD, FACP, FASCO, Invites You to the 2015 ASCO Annual Meeting"><font color="#00447d">ASCO President Peter Paul Yu, MD, FACP, FASCO, Invites You to the 2015 Annual Meeting &#187;</font></a></font> </font>
			</p>
			</td>
		</tr>
	</tbody>
</table></td></tr></table></td></tr></table></td>
																						</tr>
																					</table>
																				</td>
																			</tr>
																		</table>
																	</td>
																</tr>
																<tr>                                             
																	<td align="left" width="600" style="padding: 0px 30px 30px 30px;">
																		<table cellpadding="0" cellspacing="0" border="0" width="540">
																			<tr>
																				<td align="left" valign="top" width="255" height="" style="padding: 0px 30px 0px 0px;">
																					<table cellpadding="0" cellspacing="0" border="0" width="255">
																						<tr>
																							<td align="left" width="255"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><table class="dashedBorder" bgcolor="#ffffff" width="100%" cellpadding="0" cellspacing="0">
	<tbody>
		<tr>
			<td style="font-family: Arial; height: 4px; font-size: 13px;" align="left" bgcolor="#dbdfea" height="4" valign="middle"><img style="display: block;" src="http://image.broadcastemail.asco.org/lib/fe551570776d037a7c13/m/1/spacer.gif" height="4" width="255" /></td>
		</tr>
		<tr>
			<td style="font-family: Arial; height: 2px; font-size: 13px;" align="left" bgcolor="#ffffff" height="2" valign="middle"><img style="display: block;" src="http://image.broadcastemail.asco.org/lib/fe551570776d037a7c13/m/1/spacer.gif" height="2" width="255" /></td>
		</tr>
		<tr>
			<td style="font-family: Arial; height: 2px; font-size: 13px;" align="left" bgcolor="#dbdfea" height="2" valign="middle"><img style="display: block;" src="http://image.broadcastemail.asco.org/lib/fe551570776d037a7c13/m/1/spacer.gif" height="2" width="255" /></td>
		</tr>
		<tr>
			<td style="font-family: Arial; height: 30px; font-size: 18px;" align="left" bgcolor="#ffffff" height="30" valign="middle"><strong><font color="#00447d">AS</font></strong><a class="bookmark" title="ASCO in Action" name="ASCO in Action"></a><strong><font color="#00447d">CO in Action<br /></font></strong></td>
		</tr>
		<tr>
			<td style="font-family: Arial; height: 1px; font-size: 13px;" align="left" bgcolor="#dbdfea" height="1" valign="middle"><img style="display: block;" src="http://image.broadcastemail.asco.org/lib/fe551570776d037a7c13/m/1/spacer.gif" height="1" width="255" /></td>
		</tr>
	</tbody>
</table></td></tr></table></td></tr></table></td>
																						</tr>
																						<tr>
																							<td align="left" width="255"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><br />
<font color="#00447d"><a style="text-decoration: none;" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd64117127cc18b1ef2912d43a22de3bcc1994e7621ac9eb31cbc7d36daf3eaee5" title="Senate Delays Vote on SGR Repeal; Ongoing Action Needed"  ><font color="#00447d">Senate Delays Vote on SGR Repeal; Ongoing Action Needed &#187;
</font></a><font color="#00447d">
<p>
<a style="text-decoration: none;" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdfc214395f6a7d5fff8bee173a699e075dd5cc1ed8a462dbf2bdd6f57753b7fc9" title="Tell Congress to Permanently Repeal the SGR Before March 31"  >
</a><a title="Congress Takes Closer Look at 340B Program" style="text-decoration: none;" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd73d73315985614c57adc9eb821470e9d8b2ff769ac255decd64438d93cf7179f"  ><font color="#00447d">Congress Takes Closer Look at 340B Program &#187;</font></a>
</p>
</font></font> 

<a title="FDA's Biosimilar Product Approval Process: A Closer Look" style="text-decoration: none;" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd00b643063034b2bb2763b0cafbbea7dc5c16093ba058341a3eb3cd3014f5dc25"  ><font color="#00447d">FDA's Biosimilar Product Approval Process: A Closer Look &#187;</font></a>
<br />
<br /></td></tr></table></td></tr></table></td>
																						</tr>
																						<tr>
																							<td align="left" width="255"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><table class="dashedBorder" bgcolor="#ffffff" width="100%" cellpadding="0" cellspacing="0">
	<tbody>
		<tr>
			<td style="font-family: Arial; height: 4px; font-size: 13px;" align="left" bgcolor="#dbdfea" height="4" valign="middle"><img style="display: block;" src="http://image.broadcastemail.asco.org/lib/fe551570776d037a7c13/m/1/spacer.gif" height="4" width="255" /></td>
		</tr>
		<tr>
			<td style="font-family: Arial; height: 2px; font-size: 13px;" align="left" bgcolor="#ffffff" height="2" valign="middle"><img style="display: block;" src="http://image.broadcastemail.asco.org/lib/fe551570776d037a7c13/m/1/spacer.gif" height="2" width="255" /></td>
		</tr>
		<tr>
			<td style="font-family: Arial; height: 2px; font-size: 13px;" align="left" bgcolor="#dbdfea" height="2" valign="middle"><img style="display: block;" src="http://image.broadcastemail.asco.org/lib/fe551570776d037a7c13/m/1/spacer.gif" height="2" width="255" /></td>
		</tr>
		<tr>
			<td style="font-family: Arial; height: 30px; font-size: 18px;" align="left" bgcolor="#ffffff" height="30" valign="middle"><strong><font color="#00447d">Journal</font></strong><a class="bookmark" title="Journals" name="Journals"></a><strong><font color="#00447d">s</font></strong></td>
		</tr>
		<tr>
			<td style="font-family: Arial; height: 1px; font-size: 13px;" align="left" bgcolor="#dbdfea" height="1" valign="middle"><img style="display: block;" src="http://image.broadcastemail.asco.org/lib/fe551570776d037a7c13/m/1/spacer.gif" height="1" width="255" /></td>
		</tr>
	</tbody>
</table></td></tr></table></td></tr></table></td>
																						</tr>
																						<tr>
																							<td align="left" width="255"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><br />
<font color="#959595"><a   style="text-decoration: none;" needed?""="" is="" plunge="" when="" water="" the="" in="" toe="" a="" title="The State of Cancer Care in America: 2015" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd7138e8ef91e9bc612b0cd8e93587ccbc9ddd6ab58bc7e26f8683bb800e8f4ed3"><font color="#00447d"><i>JOP</i> Publishes <i>The State of Cancer Care in America: 2015</i> &#187;</font></a></font>
<br /><br />
<font color="#959595"><a style="text-decoration: none;" title="JCO's Understanding the Pathway" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd078bf8b652b78edacb4c8e0176fe3effe88a26b4e7649971bd42218093849ffa"  ><font color="#00447d"><i>JCO</i>'s Understanding the Pathway: Should the adjuvant trial results lead us away from testing PI3K inhibitors in HER2-positive breast cancer? &#187;</font></a></font>
<font color="#959595">
<p>
<font color="#959595"><font color="#959595"><a   href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd4cf950d599fe1863072663dfd921814c0a842a161272d15a928c105c066a43ea" title="Lapatinib Versus Trastuzumab in Metastatic Breast Cancer" style="text-decoration: none;"><font color="#00447d">Guidance on Lapatinib Versus Trastuzumab in Metastatic Breast Cancer &#187;</font></a></font></font></p><p><font color="#959595"><font color="#959595"><font color="#959595"><a href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd94b74ef2609977cd156bf000fcdecb8c972c9977fb1e5329ffbbbe8c7f5b297c" title="Drug Shortages Disproportionately Affect Smaller Practices" style="text-decoration: none;"  ><font color="#00447d"><i>JOP </i>Exclusive Coverage: Drug Shortages Disproportionately Affect Smaller Practices &#187;</font></a></font></font>
</font></p>
</font>
<font color="#959595"><font color="#00447d">
<font color="#959595">
<font color="#959595"><font color="#959595"><font color="#959595"><strong>Full Journals<br />
</strong></font><a title="Journal of Clinical Oncology Original Reports" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd5f1c6347a4bd233b69770943cd153862daab12f5bb98c95a8e8f223dc7dfb23b"  ><font color="#00447b"><strong>Journal of Clinical Oncology <br />
Original Reports</strong></font></a><font color="#00447b"><strong> &#187; <br />
</strong></font><br />
<font color="#00447d"><a title="Journal of Oncology Practice" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd0a3d33c46cc7d49e3e81f4e331408efdf3bde6dc014db517285300f71f9e872f"  ><font color="#00447d"><strong><font color="#00447b">Journal of Oncology Practice</font></strong></font></a><font color="#00447d"><font color="#00447b"><strong> &#187;&nbsp;<br />
&nbsp;&nbsp;<br />
</strong></font></font></font></font></font></font></font></font></td></tr></table></td></tr></table></td>
																						</tr>
																						<tr>
																							<td align="left" width="255"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><table class="dashedBorder" bgcolor="#ffffff" width="100%" cellpadding="0" cellspacing="0">
	<tbody>
		<tr>
			<td style="font-family: Arial; height: 4px; font-size: 13px;" align="left" bgcolor="#dbdfea" height="4" valign="middle"></td>
		</tr>
		<tr>
			<td style="font-family: Arial; height: 2px; font-size: 13px;" align="left" bgcolor="#ffffff" height="2" valign="middle"></td>
		</tr>
		<tr>
			<td style="font-family: Arial; height: 2px; font-size: 13px;" align="left" bgcolor="#dbdfea" height="2" valign="middle"></td>
		</tr>
		<tr>
			<td style="font-family: Arial; height: 30px; font-size: 18px;" align="left" bgcolor="#ffffff" height="30" valign="middle"><strong><a class="bookmark" title="ASCO Connection" name="ASCO Connection"><font color="#00447d">ASCO Connection</font></a></strong></td>
		</tr>
		<tr>
			<td style="font-family: Arial; height: 1px; font-size: 13px;" align="left" bgcolor="#dbdfea" height="1" valign="middle"></td>
		</tr>
	</tbody>
</table></td></tr></table></td></tr></table></td>
																						</tr>
																						<tr>
																							<td align="left" width="255"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><br />
<font color="#959595">ASCO's professional networking site for the worldwide oncology community</font><br />
<font color="#959595">
<p>
<font color="#959595"><strong>New Commentary</strong><font color="#959595"><a   style="text-decoration: none;" title="How to Assure Patients in the Face of ASSURE" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd9730bffedeff40da4edd00496987ccb52d4bdcc7b8fca48a4e732b7ab38dc504"><font color="#00447d"><br />
How to Assure Patients in the Face of ASSURE</font></a></font></font><font color="#959595"><font color="#959595"> by Sumanta K. Pal, MD, and Nicholas Vogelzang, MD, FASCO</font></font>
</p>
<p>
</p>
<p>
<font color="#959595"><font color="#959595"><font color="#959595"><a   style="text-decoration: none;" title="Through the Eyes of a Child " href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdb87794af2b25bfd27b7f865a28da6513c2128cef61630c3ca3ed0c879ccc7f4d"><font color="#00447d">Through the Eyes of a Child</font></a></font></font><font color="#959595"><font color="#959595"> by Don S. Dizon, MD, FACP </font></font><font color="#959595"><font color="#959595"><font color="#959595"><a   style="text-decoration: none;" title="@drdonsdizon" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd619715a3ad3e3c90053426f7d47e8f93e8375c3bf7f4394ef806407164837424"><font color="#00447d">@drdonsdizon</font></a></font></font></font></font>
</p>
<p>
</p>
<p>
<font color="#959595">
<font color="#959595"><font color="#959595"><font color="#959595"><a href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdc2229e112d88ad78ce21c6c769f18e9099edf73a8f0055ba6445931102d368a4" title="Unintended Consequences" style="text-decoration: none;"  ><font color="#00447d">Unintended Consequences</font></a></font></font><font color="#959595"><font color="#959595"> by Nathan A. Pennell, MD, PhD </font></font></font></font><font color="#959595"><font color="#959595"><font color="#959595"><font color="#959595"><font color="#959595"><a style="text-decoration: none;" title="@n8pennell" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdfae3adfc6c576df5c0917437bd3e011dff1aa12a31c998e9c4163e28424362f9"  ><font color="#00447d">@n8pennell</font></a></font></font></font></font></font>
</p>
</font>
<p>
</p>

<font color="#959595">
Log in to <a   href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bda255f135f2e5800729eb02abcce830cb706b69a919f766def0739d6c917fd992" title="ASCOConnection.org" style="text-decoration: none;"><font color="#00447d">ASCOconnection.org</font></a> <font color="#959595">to respond.<br />
</font>
<p>
</p>
</font></td></tr></table></td></tr></table></td>
																						</tr>
																						<tr>
																							<td align="left" width="255"></td>
																						</tr>
																						<tr>
																							<td align="left" width="255"></td>
																						</tr>
																						<tr>
																							<td align="left" width="255"></td>
																						</tr>
																						<tr>
																							<td align="left" width="255"></td>
																						</tr>
																						<tr>
																							<td align="left" width="255"></td>
																						</tr>
																					</table>
																				</td>
																				<td align="left" valign="top" width="255" height="">
																					<table cellpadding="0" cellspacing="0" border="0" width="255">
																						<tr>
																							<td align="left" width="255"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><table class="dashedBorder" bgcolor="#ffffff" width="100%" cellpadding="0" cellspacing="0">
	<tbody>
		<tr>
			<td style="font-family: Arial; height: 4px; font-size: 13px;" align="left" bgcolor="#dbdfea" height="4" valign="middle"></td>
		</tr>
		<tr>
			<td style="font-family: Arial; height: 2px; font-size: 13px;" align="left" bgcolor="#ffffff" height="2" valign="middle"></td>
		</tr>
		<tr>
			<td style="font-family: Arial; height: 2px; font-size: 13px;" align="left" bgcolor="#dbdfea" height="2" valign="middle"></td>
		</tr>
		<tr>
			<td style="font-family: Arial; height: 30px; font-size: 18px;" align="left" bgcolor="#ffffff" height="30" valign="middle"><strong><a class="bookmark" title="Meetings" name="Meetings"><font color="#00447d">Meetings</font></a></strong></td>
		</tr>
		<tr>
			<td style="font-family: Arial; height: 1px; font-size: 13px;" align="left" bgcolor="#dbdfea" height="1" valign="middle"></td>
		</tr>
	</tbody>
</table></td></tr></table></td></tr></table></td>
																						</tr>
																						<tr>
																							<td align="left" width="255"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><br />
<a   style="text-decoration: none;" title="2015 ASCO Annual Meeting" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd247ee31265322e547e5830ba66cf8df3bae1c595b7a611bccf283cf1a4c01b8e"><font color="#00447d">2015 ASCO Annual Meeting &#187;</font></a><br />
<font color="#ce7519">May 29-June 2 in Chicago, Illinois<br />
<font color="#959595"><strong>Register and Reserve Your Hotel by </strong>April 22, 2015, at 11:59 PM (EDT)</font>
<br />
<br />
<a   style="text-decoration: none;" title="Best of ASCO 2015" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd84e454896e9426a94972d4359b6ec8587f81b1818eac22ed388ea3eb624f6c9a"><font color="#00447d">Save the Date: Best of ASCO<sup>&#174;</sup> 2015 &#187;</font></a><font color="#00447d"><br />
<font color="#ce7519">July 31-August 1 in Boston, Massachusetts<br />
August 7-8 in San Francisco, California<br />
August 28-29 in Chicago, Illinois
<p><font color="#ce7519"><font color="#00447d"><font color="#ce7519"><font color="#ce7519"><a style="text-decoration: none;" title="Community Research Forum Annual Meeting" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd24ed54df6e45b53bb086d86844663d663e7f200c1393b509e10df2e281bfc324"  ><font color="#00447d">Save the Date: Community Research Forum 2015 Annual Meeting &#187;</font></a><font color="#00447d"><br />
<font color="#ce7519">September 20-21 in Alexandria, Virginia<br /></font></font></font></font></font></font></p><p>
<font color="#ce7519"><a   style="text-decoration: none;" title="Breast Cancer Symposium" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd02d70c2452eed495405c410d57b93ae22fe85cba0c5dc18e24c1bac75e296767"><font color="#00447d">Save the Date: 2015 Breast Cancer Symposium &#187;</font></a><font color="#00447d"><br />
<font color="#ce7519">September 25-27 in San Francisco, California<br />
</font></font></font>
</p>
</font></font></font><font color="#ce7519"><font color="#00447d"><font color="#ce7519"><font color="#ce7519"><a   style="text-decoration: none;" title="Palliative Care in Oncology Symposium" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd69e24477ae065d495e6d8d3acebc58b364a0e881913884371856c90616b8ebc3"><font color="#00447d">Save the Date: 2015 Palliative Care in Oncology Symposium &#187;</font></a><font color="#00447d"><br />
<font color="#ce7519">October 9-10 in Boston, Massachusetts
<p>
<font color="#ce7519"><font color="#00447d"><font color="#ce7519"><font color="#ce7519"><a style="text-decoration: none;" title="Cancer Survivorship Symposium: Advancing Care and Research" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bda65fb8e3f405df51bf3580dcec833724dd2fe873bbed1f728bc31e1ff2bae70c"  ><font color="#00447d">Announcing the Inaugural 2016 Cancer Survivorship Symposium: Advancing Care and Research &#187;</font></a><font color="#00447d"><br />
<font color="#ce7519">January 15-16, 2016 in San Francisco, California</font></font></font></font></font></font>
</p>
</font></font></font></font></font><font color="#00447d"><font color="#959595"><font color="#959595"><strong><a title="See All Upcoming Meetings" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdbda819b0590651ec30ed33ebf49353551fc94d1c81ef073625c10fd966bb83bd"  ><font color="#00447d">See All Upcoming Meetings &#187;</font></a></strong><br />
</font></font></font></font><br /></td></tr></table></td></tr></table></td>
																						</tr>
																						<tr>
																							<td align="left" width="255"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><table class="dashedBorder" bgcolor="#ffffff" width="100%" cellpadding="0" cellspacing="0"><tbody><tr><td style="font-family: Arial; height: 4px; font-size: 13px;" align="left" bgcolor="#dbdfea" height="4" valign="middle"><img style="display: block;" src="http://image.broadcastemail.asco.org/lib/fe551570776d037a7c13/m/1/spacer.gif" height="4" width="255" /></td></tr><tr>
<td style="font-family: Arial; height: 2px; font-size: 13px;" align="left" bgcolor="#ffffff" height="2" valign="middle"><img style="display: block;" src="http://image.broadcastemail.asco.org/lib/fe551570776d037a7c13/m/1/spacer.gif" height="2" width="255" /></td></tr><tr><td style="font-family: Arial; height: 2px; font-size: 13px;" align="left" bgcolor="#dbdfea" height="2" valign="middle"><img style="display: block;" src="http://image.broadcastemail.asco.org/lib/fe551570776d037a7c13/m/1/spacer.gif" height="2" width="255" /></td></tr><tr><td style="font-family: Arial; height: 30px; font-size: 13px;" align="left" bgcolor="#ffffff" height="30" valign="middle"><font size="4" color="#00447d">
<strong>Education & Training</strong></font></td></tr><tr><td style="font-family: Arial; height: 1px; font-size: 13px;" align="left" bgcolor="#dbdfea" height="1" valign="middle"><img style="display: block;" src="http://image.broadcastemail.asco.org/lib/fe551570776d037a7c13/m/1/spacer.gif" height="1" width="255" /></td></tr></tbody></table></td></tr></table></td></tr></table></td>
																						</tr>
																						<tr>
																							<td align="left" width="255"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><font color="#00447d"><a   style="text-decoration: none;" title="BRCA-Associated Breast Cancer" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bde9b60dbcc0cbaa82f4a1be4673b0964c62748670d665ad68db76679fcb85e6b2"><br />
<font color="#00447d">New CME-Accredited Tumor Board on ASCO University: BRCA-Associated Breast Cancer &#187;</font></a></font>
<br />
<br />
<font color="#00447d"><a style="text-decoration: none;" title="New Lung Cancer MOC Course" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd65c361a456ec900e9b282a412999ba87664809bb9a7ad4acb9ec9551e991f421"  ><font color="#00447d">Fulfill ABIM Requirements with New Lung Cancer MOC Course &#187;</font></a></font>
<br />
<br /><font color="#00447d"><a style="text-decoration: none;" title="GU Cancers Symposium Virtual Meeting" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd41e06688a147994f11f94efce77c8f6bd341e1f61f15504529ff92815c3074ce"  ><font color="#00447d">Missed the Genitourinary Cancers Symposium? Get Access to the Science Presented with Virtual Meeting &#187;</font></a></font>
<br />
<br /></td></tr></table></td></tr></table></td>
																						</tr>
																						<tr>
																							<td align="left" width="255"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><table class="dashedBorder" bgcolor="#ffffff" width="100%" cellpadding="0" cellspacing="0">
	<tbody>
		<tr>
			<td style="font-family: Arial; height: 4px; font-size: 13px;" align="left" bgcolor="#dbdfea" height="4" valign="middle"><img style="display: block;" src="http://image.broadcastemail.asco.org/lib/fe551570776d037a7c13/m/1/spacer.gif" height="4" width="255" /></td>
		</tr>
		<tr>
			<td style="font-family: Arial; height: 2px; font-size: 13px;" align="left" bgcolor="#ffffff" height="2" valign="middle"><img style="display: block;" src="http://image.broadcastemail.asco.org/lib/fe551570776d037a7c13/m/1/spacer.gif" height="2" width="255" /></td>
		</tr>
		<tr>
			<td style="font-family: Arial; height: 2px; font-size: 13px;" align="left" bgcolor="#dbdfea" height="2" valign="middle"><img style="display: block;" src="http://image.broadcastemail.asco.org/lib/fe551570776d037a7c13/m/1/spacer.gif" height="2" width="255" /></td>
		</tr>
		<tr>
			<td style="font-family: Arial; height: 30px; font-size: 18px;" align="left" bgcolor="#ffffff" height="30" valign="middle"><strong><a class="bookmark" title="For Your Patients" name="For Your Patients"><font color="#00447d">For Your Patients</font></a></strong></td>
		</tr>
		<tr>
			<td style="font-family: Arial; height: 1px; font-size: 13px;" align="left" bgcolor="#dbdfea" height="1" valign="middle"><img style="display: block;" src="http://image.broadcastemail.asco.org/lib/fe551570776d037a7c13/m/1/spacer.gif" height="1" width="255" /></td>
		</tr>
	</tbody>
</table></td></tr></table></td></tr></table></td>
																						</tr>
																						<tr>
																							<td align="left" width="255"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><font color="#959595"><a style="text-decoration: none;" title="Overview of Kidney Cancer in New Cancer.Net Video" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd1f9f16badeb2fa1e76a2bb832bc31ec7e3b147c5e7732259b8bf4471934b902f"  ><font color="#00447d"><br />
Dr. Brian Rini Provides an Overview of Kidney Cancer in New Cancer.Net Video &#187;</font></a><font color="#00447d">
<br />
<br />
<font color="#959595"><a style="text-decoration: none;" title="A Behind-the-Scenes Q&A with Pathologists" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd1eb5e89b26b2580379a35becc38084f545ccb1c2995ec82718620fe8717bfb18"  ><font color="#00447d">Now on the Cancer.Net Blog: A Behind-the-Scenes Q&A with Pathologists &#187;</font></a></font>
</font><font color="#00447d">
<br />
<br />
</font>
</font></td></tr></table></td></tr></table></td>
																						</tr>
																						<tr>
																							<td align="left" width="255"></td>
																						</tr>
																						<tr>
																							<td align="left" width="255"></td>
																						</tr>
																						<tr>
																							<td align="left" width="255"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><table width="100%" cellspacing="0" cellpadding="10" bgcolor="#fff0cf" style="border: 1px solid #ffd457;">
	<tbody>
		<tr>
			<td>
			<table width="100%" cellspacing="0" cellpadding="0" bgcolor="#fff0cf" class="dashedBorder">
				<tbody>
					<tr>
						<td style="padding-bottom: 5px; font-family: Arial; font-size: 13px;"><a title="Twitter" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdc55b3e3e35db115b9211f9cd121556d506399ed9761c082d9fd92df5faa58288"  ><img width="15" height="15" border="0" style="border-color: #000000; margin: 0px; width: 15px; height: 15px;" title="ASCO_Icon_Twitter" alt="ASCO_Icon_Twitter" src="http://image.broadcastemail.asco.org/lib/fe66157077670d7f7712/m/1/ASCO_Icon_Twitter.jpg" mdid="31dd2f68-e789-4d9e-b806-7c5a4d049498" /></a></td>
						<td style="padding-bottom: 5px; padding-left: 5px; font-family: Arial; font-size: 13px;"><font color="#252525">Follow us on <strong><a title="Twitter" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd2b4be261fc8d2e7ddf5c567e011a1e6eec42a5a9b26cff4947a8bdca5f475001"  ><font color="#00447d">Twitter</font></a></strong></font></td>
					</tr>
					<tr>
						<td style="padding-bottom: 5px; font-family: Arial; font-size: 13px;"><a title="Facebook" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd09be06e2d7aee29d90254a1deb1b1075f4263e7890590a2510840e14d6651121"  ><img width="15" height="15" border="0" style="border-color: #000000; margin: 0px; width: 15px; height: 15px;" title="ASCO_Icon_Facebook" alt="ASCO_Icon_Facebook" src="http://image.broadcastemail.asco.org/lib/fe66157077670d7f7712/m/1/ASCO_Icon_Facebook.jpg" mdid="04d51018-98ed-4876-96ff-d5cb8f5ad66a" /></a></td>
						<td style="padding-bottom: 5px; padding-left: 5px; font-family: Arial; font-size: 13px;"><font color="#252525">Like us on <strong><a title="Facebook" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd9f3428c71c5ffbc6148301011d1407790ebc09075667c3a05402cf2e700e8fc5"  ><font color="#00447d">Facebook</font></a></strong></font></td>
					</tr>
					<tr>
						<td style="padding-bottom: 5px; font-family: Arial; font-size: 13px;"><a title="LinkedIn" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bda4dbf46ff29113bb612fb497cfdb6dcf3a3a3e649c801aa624868a55ec021ba9"  ><img width="15" height="15" border="0" style="border-color: #000000; margin: 0px; width: 15px; height: 15px;" title="ASCO_Icon_LinkedIn" alt="ASCO_Icon_LinkedIn" src="http://image.broadcastemail.asco.org/lib/fe66157077670d7f7712/m/1/ASCO_Icon_LinkedIn.jpg" mdid="a49c29e5-6288-437a-adef-c9788d563a57" /></a></td>
						<td style="padding-bottom: 5px; padding-left: 5px; font-family: Arial; font-size: 13px;"><font color="#252525">Follow us on <strong><a title="LinkedIn" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bda3d05b2e9a0947167eec4038992df28d9bfe1e5f2c11821100aaead486a741c2"  ><font color="#00447d">LinkedIn</font></a></strong></font></td>
					</tr>
					<tr>
						<td style="padding-bottom: 5px; font-family: Arial; font-size: 13px;"><a title="YouTube" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd7ea69e73664a42b9dd8ef07cb130306e36c43fabedf6d26286519478373eb5bc"  ><img width="15" height="15" border="0" style="border-color: #000000; margin: 0px; width: 15px; height: 15px;" title="ASCO_Icon_YouTube" alt="ASCO_Icon_YouTube" src="http://image.broadcastemail.asco.org/lib/fe66157077670d7f7712/m/1/ASCO_Icon_YouTube.jpg" mdid="c5ed8f01-50b2-4962-a2a0-6b60c4ead0b7" /></a></td>
						<td style="padding-bottom: 5px; font-family: Arial; font-size: 13px;"><font color="#252525">&nbsp;Watch us on <strong><a title="YouTube" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdb0951f271511217f51440940a35dc565fb173eaafe8de52fa13af05a98256083"  ><font color="#00447d">YouTube</font></a>
						</strong></font></td>
					</tr>
					<tr>
						<td style="padding-bottom: 5px; font-family: Arial; font-size: 13px;"><a title="ASCO Connection" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdbb283a4aa29803bd108904eac45ad0e1c135f68e8f1f5cfcc8cb13742bc569fc"  ><img width="15" height="15" border="0" style="border-color: #000000; margin: 0pt; width: 15px; height: 15px;" title="ASCO Connection" alt="ASCO Connection" src="http://image.broadcastemail.asco.org/lib/fe551570776d037a7c13/m/1/ACicon-15x15.gif" mdid="f36055ed-583b-48e0-9145-f5cf965aea03" /></a></td>
						<td style="padding-bottom: 5px; padding-left: 5px; font-family: Arial; font-size: 13px;"><font color="#252525">Network on <strong><a title="ASCO Connection" href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bdbb283a4aa29803bd108904eac45ad0e1c135f68e8f1f5cfcc8cb13742bc569fc"  ><font color="#00447d">ASCO Connection</font></a></strong></font></td>
					</tr>
				</tbody>
			</table>
			</td>
		</tr>
	</tbody>
</table></td></tr></table></td></tr></table></td>
																						</tr>
																						<tr>
																							<td align="left" width="255"></td>
																						</tr>
																						<tr>
																							<td align="left" width="255"></td>
																						</tr>
																					</table>
																				</td>
																			</tr>
																		</table>
																	</td>
																</tr>
																<tr>                                             
																	<td align="left" width="600" height="10"><img alt="" src="http://image.broadcastemail.asco.org/lib/fe66157077670d7f7712/m/1/ASCO_Footer_Corners.gif" width="600" height="10" border="0" style="display: block;"></td>
																</tr>
															</table>
														</td>
													</tr>
													<!-- END Email Body -->
													<!-- Footer  -->
													<tr>
														<td align="left" width="540" style="padding: 30px 30px 30px 30px;"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><table class="dashedBorder" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td><span class="Apple-style-span" style="font-size: 12px;">
<img src="http://image.broadcastemail.asco.org/lib/fe551570776d037a7c13/m/1/CCF_Logo_White_smallest.png" title="CCF_Logo_White_smallest" alt="CCF_Logo_White_smallest" mdid="eeebe5ef-c6ef-48ac-92aa-d4bd8d014d79" style="width: 78px; height: 25px;" border="0" height="25" hspace="18" vspace="0" width="78" /></span></td><td><p style="font-family: Arial;"><font class="Apple-style-span" size="1"><font style="background-color: #00447d;" color="#ffffff">The Conquer Cancer Foundation supports many of ASCO's programs.&nbsp;</font><a href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd6c368bd221129b7413e698bdb01852a8adfea0387fd60f3f3f1a8861545f16c4" title="Click here"   style="color: #ffffff;">Click here</a>&nbsp;
<font href="http://www.conquercancerfoundation.org/" title="Click here" alias="Click here" false="" style="background-color: #00447d;" color="#ffffff"><font color="#ffffff">to join us in building a world free from the fear of cancer.</font></font></font></p></td></tr></tbody></table></td></tr></table></td></tr></table></td>
													</tr>
													<!-- END Footer -->
												</table>
												<!-- END Content -->
											</td>
										</tr>
									</table>
									<!-- END Table used to set width of email content -->
							</td>
						</tr>
					</table>
					<!-- END Table use to set width of email margin -->
				</div>
			</td>
		</tr>
	</table>
	<!-- END Table used to center email -->
	<img src="http://click.broadcastemail.asco.org/open.aspx?ffcb10-fe531775726c0d7c7012-fdc61574706c037c7112727664-fe6615707d6705797316-fe6415787165027c7710-fe271d7877640475761579-ff5e177970" width="1" height="1">
 <!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<title></title>
</head><body>
<body>


<div width="850" style="margin-left: auto; margin-right: auto; width: 850px; text-align: left;">

You are receiving this email because you have an existing relationship
with ASCO.&nbsp; Visit your personalized <a
href="http://click.broadcastemail.asco.org/?qs=7aec27c66c4842bd4d071c8191851e3b6585b2e6e492ea02fca180a1f55d6d2cfed989c4db7119b4aaa6160a7e8d0456"
target="_blank">Preference Center</a> to unsubscribe or to select
your preferences for receiving ASCO promotional email.&nbsp; Please do
not reply to this email.&nbsp; <br>
This email was sent by: American Society of Clinical Oncology<br>
2318 Mill Road, Suite 800 Alexandria, VA,
22314, USA<br></div>
</body>
</body>
</html>

--8T1XV8FMHUz6=_?:--

